Kaya Ltd (KAYA)
🎯 Key Takeaways
- Kaya Ltd is in a strategic transformation phase, actively raising capital through a preferential issue and expanding its leadership structure to support long-term growth. Management is focused on capital allocation for expansion and operational initiatives through FY28, signaling a shift from current losses toward future scalability.
- Revenue declined 7.1% QoQ to ₹56 in Q4FY26.
- ⚠️ Persistent operating losses and negative margins despite stable revenue, with no clear path to profitability disclosed.
- Market Cap
- ₹488
- P/B Ratio
- -3.19
- ROE
- 63.0%
- ROCE
- -579.5%
- Debt/Equity
- -1.07
- Promoter
- 51.4%
📖 The Story
Kaya Ltd is in a strategic transformation phase, actively raising capital through a preferential issue and expanding its leadership structure to support long-term growth. Management is focused on capital allocation for expansion and operational initiatives through FY28, signaling a shift from current losses toward future scalability. The company maintains strong promoter holding and governance continuity, but faces significant financial and operational challenges.
📰 What's Happening
In August 2026, the board approved a preferential issue of 18.24 lakh shares at ₹274.10 to non-promoter investors Axana Estates LLP and Plutus Investments India Private Limited, subject to shareholder approval via an EGM scheduled for September 5, 2026. Concurrently, the ESOP pool under the 2021 plan was increased by 4 lakh options to 12.03 lakh, reflecting intent to incentivize key personnel. The company also re-appointed Ms. Vasuta Agarwal as Independent Director for a second term and Rishabh Mariwala as Managing Director for five years, reinforcing leadership continuity. Management intends to utilize proceeds for capital expenditure (50%), working capital (25%), and general corporate purposes (up to 25%) through FY28.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 53 | 54 | 60 | 56 |
| Operating Profit | -6 | -14 | -23 | -24 |
| OPM % | -11.8% | -26.5% | -38.3% | -43.5% |
| Net Profit | -14 | -19 | -36 | -28 |
| EPS | ₹-10.76 | ₹-13.18 | ₹-23.41 | ₹-18.28 |
Quarterly revenue has remained relatively flat around ₹53–60 crore over the last four quarters, but operating performance has deteriorated, with operating losses widening from ₹-6 crore in Jun 2025 to ₹-24 crore in Mar 2026, and OPM declining from -11.8% to -43.5%. Net losses have increased from ₹-14 crore to ₹-28 crore, and EPS has turned more negative from ₹-10.76 to ₹-18.28, indicating growing pressure on profitability despite stable top-line. This trend suggests rising operational costs or investments outpacing revenue growth, which management is attempting to fund through the proposed capital raise.
🔮 Management Outlook & What's Next
Management has explicitly stated that the funds from the preferential issue will be utilized until the conclusion of FY28, primarily for capital expenditure, working capital, and general corporate purposes. No specific revenue or profitability targets were disclosed in the filings, but the capital raise is framed as a strategic step to support expansion initiatives. The re-appointment of Rishabh Mariwala as MD and expansion of the ESOP pool suggest a focus on long-term leadership stability and talent retention as part of a broader growth strategy.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 13 | 13 | 15 | 15 |
| Reserves | -153 | -152 | -168 | -108 |
| Borrowings | 256 | 233 | 163 | 278 |
| Total Liabilities | 237 | 255 | 278 | 308 |
| Fixed Assets | 157 | 155 | 193 | 182 |
| Investments | 4 | 15 | 39 | 58 |
| Total Assets | 237 | 255 | 278 | 308 |
The balance sheet shows a sharp rise in total borrowings from ₹256 crore in Mar 2025 to ₹278 crore in Mar 2026, while equity and reserves have deteriorated, with reserves turning deeply negative from ₹-153 crore to ₹-108 crore and equity remaining flat at ₹15 crore. This indicates increasing leverage and weakening equity buffers, likely driven by accumulated losses. The company is highly leveraged with negative net worth trends, raising concerns about financial resilience unless the capital raise successfully funds growth that improves profitability.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +21 |
| Investing | -63 |
| Financing | +37 |
| Net Cash Flow | -6 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 51.4% | 51.4% | 51.4% | 51.4% |
| FII | 0.6% | 0.6% | 0.7% | 0.7% |
| DII | 2.5% | 2.8% | 3.0% | 3.0% |
| Public | 22.0% | 21.9% | 22.5% | 23.2% |
| # Shareholders | 18,724 | 18,295 | 17,932 | 18,043 |
Promoter holding remains stable at 51.43% over the last five quarters, indicating no dilution or sale by promoters. However, institutional interest is minimal, with FII holding flat at around 0.63–0.71% and DII slightly increasing from 2.53% to 2.99%. The number of public shareholders has declined slightly from 18,724 to 18,043, suggesting modest retail attrition. There are no signs of institutional accumulation, and the modest rise in DII may reflect passive or speculative interest rather than strategic conviction.
⚖️ Peer Comparison — Healthcare
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| APOLLOHOSP | 1.27 L Cr | 61.0 | 22.1% | — | 0.60 |
| MAXHEALTH | 97,412 | 66.8 | 14.4% | — | 0.27 |
| MANIPALHOS | 94,970 | — | — | — | 1.25 |
| ASTERDM | 65,184 | 121.0 | 12.9% | — | 0.17 |
| FORTIS | 62,782 | 59.9 | 13.3% | — | 0.29 |
| MEDANTA | 38,551 | 69.3 | 21.9% | — | 0.10 |
| NH | 37,160 | 45.3 | 13.7% | — | 1.07 |
| LALPATHLAB | 32,549 | 46.8 | 29.6% | — | 0.00 |
| KIMS | 32,181 | 150.2 | 9.7% | — | 1.44 |
| POLYMED | 16,587 | 52.6 | 15.1% | — | 0.06 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Persistent operating losses and negative margins despite stable revenue, with no clear path to profitability disclosed. 2. High leverage and deteriorating balance sheet metrics, including negative reserves and rising borrowings, which increase financial risk. 3. Dilution risk from the proposed preferential issue to non-promoter investors, which could pressure share price and sentiment. 4. Dependence on shareholder approval for key governance changes and capital raises, introducing execution uncertainty.
📋 Recent Filings
- Announcement2026-09-24Kaya Limited announced the closure of its trading window for designated persons and immediate relatives effective October 1, 2026, until 48 hours afte…
- 🟡 voting results2026-09-07Kaya Ltd held an EGM on September 5, 2026, approving three key resolutions: appointing Harsh Mariwala as Chairman effective November 1, 2026, appointi…
- 🟡 Board Meeting2026-09-05Kaya Ltd held an EGM on September 5, 2026, approving a special resolution to issue equity shares on a preferential basis, appoint Harsh Mariwala as Ch…
- 🔴 Announcement2026-09-02Kaya Ltd announced the resignation of Vice President and Head of IT Lokesh Wagadre, effective November 30, 2026, following his acceptance of an extern…
- 🟡 voting results2026-08-12Kaya Limited announced an EGM on September 5, 2026, to seek shareholder approval for a [amount not verified] preferential issue of 18,24,150 shares at…
- 🟡 Board Meeting2026-08-10Kaya Limited announced the outcome of its August 10, 2026 board meeting, approving a preferential issue of 18.24 lakh equity shares at ₹274.10 per sha…
- Announcement2026-08-10Kaya Limited announced on August 10, 2026 that its Nomination and Remuneration Committee approved the grant of 75,000 stock options under the Employee…
- 🟡 Board Meeting2026-08-07Kaya Limited announced the re-appointment of Ms. Vasuta Agarwal as an Independent Director for a five-year term starting August 3, 2026, approved by s…
- 🟡 Board Meeting2026-08-07Kaya Limited held its 23rd Annual General Meeting on August 7, 2026 via video conferencing. Shareholders approved the audited standalone and consolida…
- Announcement2026-08-03Kaya Limited announced board decisions on August 3, 2026, appointing Mrs. Shilpa Rathi as Company Secretary and Compliance Officer, and Ms. Bindiya Va…
🧠 Analyst's Read
Kaya Ltd is navigating a high-risk transformation with limited visibility on when or how profitability will emerge. Investors should monitor the outcome of the September 5 EGM and the deployment of raised capital toward strategic initiatives. The company's future hinges on management's ability to convert funding into sustainable operational improvement, making near-term execution and margin recovery critical watchpoints.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when KAYA files new disclosures
Track KAYA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track KAYA — FreeFree account · 2 AI queries/day